Sanofi: No 'Causal Relationship' Proven Between Acomplia and Suicidality

Sanofi-Aventis on June 13th insisted that no "causal relationship" has been established between diet drug rimonabant (Acomplia / Zimulti) and "suicidality," but pledged to immediately begin asking all patients in ongoing clinical...

FDA: 30 Percent of U.S. Patients on Diet Drugs Also Take Antidepressants

While Sanofi-Aventis says patients on antidepressants should not take diet-drug rimonabant (Acomplia / Zimulti), the FDA says data it obtained for 2004-2006 showed that 30 percent of the 580,000 patients prescribed diet pills...

Feds Reject French Weight-Loss Drug

FDA Panel Heard Testimony That Rimonabant Increases Risk Of Suicidal Thoughts

Diet Pill Rimonabant (Acomplia / Zimulti) Facing Moment of Truth in Week Ahead

Diet drug rimonabant (Acomplia / Zimulti) faces its moment of truth in the United States during the week ahead.

On Tuesday, June 12th, the FDA staff will for the first time reveal its views on the long-delayed diet drug.

The...

Diet Pill Rimonabant (Acomplia / Zimulti) Now on Sale in United Arab Emirates

Diet drug rimonabant (Acomplia / Zimulti) is now available in the United Arab Emirates for treatment of abdominally obese patients with cardiometabolic risk factors, according to a June 4th announcement by developer...